Delivery Order SPE2DB24D2012-SPE2DB25FBWVR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cipro 5% suspension in 100ml quantities, with a ceiling value of $1,332.60 under a firm fixed-price contract structure. This non-competitive delivery order was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery supports the federal...
- The Defense Logistics Agency awarded a $1,089.72 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through competitive procedures with no set-aside designation, and the product will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,578.64 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a ciprofloxacin-based antibiotic pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating...
- The Defense Logistics Agency awarded a delivery order valued at $1,461.98 to AmerisourceBergen Drug Corp for Cipro 5% Suspension in 100ml quantities, with a firm fixed price contract type. The award was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML with a ceiling value of $1,079.02. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 billion through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Cipro 500 mg tablets (100 count) at a ceiling value of $1,567.80. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cipro (ciprofloxacin) 250 mg tablets in quantities of 100 units, with a contract ceiling value of $1,564.92. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a pediatric or smaller-quantity pharmaceutical procurement utilizing AmerisourceBergen's existing contract vehicle. The award was not designated as a set-aside and...
- The Defense Logistics Agency awarded a delivery order valued at $4,210.72 to AmerisourceBergen Drug Corp for Cipro 10% Suspension 100ML, a broad-spectrum antibiotic pharmaceutical product. The contract utilized firm fixed price pricing with no set-aside designation, indicating competitive award through an open procurement process. The delivery order is scheduled for completion by August 1, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cipro 500 mg tablets (100-count units) at a ceiling value of $1,185.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 14, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.05 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a fluoroquinolone antibiotic commonly used to treat bacterial infections across military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWVRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Cipro 5% Suspension in 100ml quantities, with a ceiling value of $1,482.16 and an ultimate completion date of September 3, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this delivery order under its substantially larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The SPE2DX prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. This strategic contract vehicle encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains for customers including the Defense Health Agency and other federal healthcare systems. The current delivery order for Cipro, a fluoroquinolone antibiotic, represents a routine pharmaceutical fulfillment within the broader scope of AmerisourceBergen Drug Corp's extensive federal medical supply portfolio administered through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/2/25 |